Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
about
Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary studyIfosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.Surgical management of 143 patients with adult primary retroperitoneal tumor.Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.High-risk soft tissue sarcoma: clinical trial and hyperthermia combined chemotherapy.Lymph node metastasis after a soft tissue sarcoma of the leg: a case report and a review of the literature.Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990.Hyperthermia as an adjunctive treatment for soft-tissue sarcoma.The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers.Hyperthermia in soft tissue sarcoma.Management of recurrent retroperitoneal sarcoma.Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas.Practical Issues for Retroperitoneal Sarcoma.An unresectable retroperitoneal malignant fibrous histiocytoma: A case report.Hyperthermia enhances tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human cancer cells.[Multimodality therapy concepts for soft tissue sarcomas].Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS).Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study.A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis.Long-term results of primary and secondary resections in patients with retroperitoneal soft tissue sarcoma.
P2860
Q33301768-E84BDEDA-2E89-418B-9B11-2D672C3E70B9Q33362634-3FAD5D28-EDCA-459C-8E86-B2EEBA47F65DQ34098831-DED4ADE5-6329-487F-98F0-015A6DC2AF9EQ36454797-D3B79ED8-2808-48D6-B438-735B7BA83690Q36497626-CF28B9C0-E0D9-4A08-BD4A-E4BC09F75A47Q36634514-4BC9B426-C322-46D6-9A83-E1B837BCFFB4Q36691054-6B529430-B5D9-4F18-99B5-2FA2F32C11C2Q37385380-09219376-6C70-4C22-A6BB-F8159007ACB9Q37389930-8B7B201B-BB21-4985-80F9-2715F658F1D3Q37468623-7E1BBE7C-1DBD-416F-8EAE-348345D0D11DQ37848208-BA7D63D4-A495-4A69-AD5B-58F4E39CE583Q38155133-6019AF3B-AA86-433C-9543-9A3D00FD93EDQ38840133-DBD61AED-FCED-44A4-BCA7-D22CD867AF99Q38936009-FCBCC576-D0AC-4BC4-8AB7-4E5BFEE30EE7Q39644087-8A6F89AB-02D5-4660-8C6C-BF721BBADF99Q40153288-D6D59AE4-A54A-40A5-87D0-D1C78236D6E4Q42861828-F35A1307-2196-4BA6-9C30-B99A69914814Q43166296-114032A0-45C7-4998-9E51-04E26310C176Q43294327-17C2EEDE-0D4A-46E9-A1D5-068321166A20Q44942121-9EA63777-08E3-4B6F-8DC2-F139E476539BQ51168424-58AF9969-8351-49C6-896C-97A622532B75Q53646017-A99F8B31-1978-4486-ACD4-0E9A9BB01225
P2860
Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Response to neoadjuvant chemot ...... igh-risk soft tissue sarcomas.
@en
Response to neoadjuvant chemot ...... igh-risk soft tissue sarcomas.
@nl
type
label
Response to neoadjuvant chemot ...... igh-risk soft tissue sarcomas.
@en
Response to neoadjuvant chemot ...... igh-risk soft tissue sarcomas.
@nl
prefLabel
Response to neoadjuvant chemot ...... igh-risk soft tissue sarcomas.
@en
Response to neoadjuvant chemot ...... igh-risk soft tissue sarcomas.
@nl
P2093
P356
P1476
Response to neoadjuvant chemot ...... igh-risk soft tissue sarcomas.
@en
P2093
Andrea Baur
Clemens-M Wendtner
Jens Baumert
Matthäus Krych
Rolf D Issels
Sultan Abdel-Rahman
Wolfgang Hiddemann
P304
P356
10.1200/JCO.2002.07.146
P407
P577
2002-07-01T00:00:00Z